Gilead Sciences is a bio-pharmaceutical research and development company that discovers, develops and commercializes innovative medicines in areas of unmet medical need. Recently, Gilead lost a patent infringement case to Merck, another pharmaceuticals company, and was ordered to pay $200 million in royalties for a pair of hepatitis C drugs, Sovaldi and Harvoni. The combined […]
The post Gilead Sciences Loses 200 Million Dollar Case to Merck appeared first on Rogers DVS, written by Graham Rogers DVS. http://ift.tt/2bgiKe4
via Tumblr http://ift.tt/2bflmWb
No comments:
Post a Comment